Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2019

Mar 22, 2019

33899_dirs_2019-03-22_94cdf9d0-49b0-480b-b638-ca26281f1810.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2019-03-20

Reporting Person: SASSANO CARL E (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-03-20 Common Stock M 5000.00 $27.68 Acquired 18156.00 Direct
2019-03-20 Common Stock M 486.00 $26.52 Acquired 18642.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-03-20 Stock Option (Right to Buy) $27.68 M 5000.00 Disposed 2026-02-04 Common Stock (5000.00) Direct
2019-03-20 Stock Option (Right to Buy) $26.52 M 486.00 Disposed 2024-02-05 Common Stock (486.00) Direct

Footnotes

F1: These options vested in three equal annual installments beginning on February 4, 2017.

F2: These options vested in three equal annual installments beginning on February 5, 2015.